FdaApplication
BLA 761427
Identifiers
- fda_app_no: BLA761427
Properties
| Property | Value |
|---|---|
| applicant_name | LIB Therapeutics, Inc. |
| application_type | BLA |
| approval_date | 2025-12-12 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEROCHOL | LERODALCIBEP-LIGA | 300MG/1.2ML (250MG/ML) | Injection |
| LEROCHOL | — | 300MG/1.2ML (250MG/ML) | Injection |
2 products